About us|Cardiac Arrest|LUCAS CPR|For users|News & Media|Contact|

News archive

LUCAS creates a new approach for saving cardiac arrest patients with suspected myocardial infarction

Lund, Sweden, 4th of December 2008

In an review article by Dr K Sunde, Ullevål University Hospital in Oslo, Norway, it is concluded that LUCAS Chest Compression System creates a new approach for treatment of sudden cardiac arrest patients in the cath lab. The article, published in Critical Care Medicine this month, contains a review of literature using continuous mechanical chest compressions during angiography and PCI (percutaneuous coronary intervention). PCI is a treatment recommended for heart attack patients – which in turn is the most common single cause of sudden cardiac arrest.

Whereas heart attack patients are transported urgently to the hospital for an emergency PCI (coronary intervention), cardiac arrest patients are only transported for a PCI if their hearts already have been restarted with a defibrillator. Only a very small fraction of the out-of-hospital cardiac arrest patients are saved today, around 6-8%. If the coronary arteries could be assessed and treated during LUCAS-supported circulation, maybe more can be saved.

Dr Sunde writes;
“[…] it is therefore very relevant to start consider the use of PCI already during ACLS [Advance Coronary Life Support] in patients not achieving early ROSC [Return of spontaneous circulation]. The most important beneficial effect with the mechanical devices is their capability of delivering good quality uninterrupted chest compressions both during the PCI procedure, but also during ambulance transport”

Moreover he discusses;
[…] “The challenge is to identify patients as early as possible and get them fast tot the angiographic laboratory.”

The quality of cardiopulmonary resuscitation is critical during prolonged resuscitation efforts to sustain vital blood circulation to the heart and brain. All case reports on mechanical chest compressions during PCI or angiography have used the LUCAS device, confirming that the device is feasible to use in this setting.

The article is called; Experimental and clinical use of ongoing mechanical cardiopulmonary resuscitation during angiography and percutaneous coronary intervention, written by Kjetil Sunde. Published in Crit Care Med 2008 Vol. 36, No. 11 (Suppl.)

Information about LUCAS scientific publications can be found www.lucas-cpr.com.

The LUCAS™ Chest Compression System helps ambulance and hospital personnel to save patients suffering sudden cardiac arrest. The device performs continuous chest compressions to maintain blood flow to the brain and heart. International resuscitation guidelines issued in 2005 stress the importance of effective and uninterrupted chest compressions prior to defibrillation. LUCAS performs chest compressions in accordance with these guidelines, without risking quality variations or tiring out personnel. The device has been shown to increase blood circulation in the patient and to be as safe as manual compressions. It allows for a safe transportation and simultaneous interventions such as defibrillation and angiography.

About Jolife AB
Jolife is dedicated to increasing the survival chances of people suffering sudden cardiac arrest, and to increasing the number who survive with their quality of life intact. This is being achieved by leading research and development in the field, in order to offer innovative products that define the future treatment of sudden cardiac arrest. The company was founded in 2000 and has since worked closely with leading physicians and paramedics on research and development. This work has resulted in groundbreaking knowledge about the physiological effects of cardiac arrest and the importance of high-quality chest compressions. The LUCAS Chest Compression System is sold in the US, Europe and other parts of the world. Based in Lund in southern Sweden, Jolife markets its products through an exclusive global distribution agreement with Physio-Control, Inc., a division of Medtronic Ltd – except in Sweden, Norway and Finland, where Jolife sells direct. For more information, please visit www.jolife.com or www.lucas-cpr.com.

Latest news
Train on LUCAS™

Physio-Control Inc. / Jolife AB, Ideon Science Park, SE-223 70 Lund, Sweden, Tel: +46 (0) 46 286 50 00, Fax: +46 (0) 46 286 50 10, info@lucas-cpr.com
Powered by Publiciteta&Co